Chargement en cours...

Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer

In the last decades, the prognosis of metastatic renal cell carcinoma (mRCC) has remarkably improved following the advent of the “targeted therapy” era. The expanding knowledge on the prominent role played by angiogenesis in RCC pathogenesis has led to approval of multiple anti-angiogenic agents suc...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Oncol
Auteurs principaux: D'Aniello, Carmine, Berretta, Massimiliano, Cavaliere, Carla, Rossetti, Sabrina, Facchini, Bianca Arianna, Iovane, Gelsomina, Mollo, Giovanna, Capasso, Mariagrazia, Pepa, Chiara Della, Pesce, Laura, D'Errico, Davide, Buonerba, Carlo, Di Lorenzo, Giuseppe, Pisconti, Salvatore, De Vita, Ferdinando, Facchini, Gaetano
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6917607/
https://ncbi.nlm.nih.gov/pubmed/31921657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01400
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!